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Summary 
 
Major Depression (MD) is a common and debilitating psychiatric disorder, affecting about 
7.5% of adolescents. The disorder is associated with many adverse consequences, such as 
impairments in interpersonal relationships, difficulties at school, and heightened suicide 
risk. The factors contributing to the complex etiology of MD are manifold. Of note is that 
traumatic experiences like maltreatment during especially vulnerable developmental peri-
ods, such as youth, are potent risk and maintaining factors contributing to MD. In addition, 
psychosocial stressors which are prevalent in everyday life, such as those occurring at 
school and in family and peer contexts, are supposed to play an important role in the devel-
opment of MD. It is also known that sociodemographic stressors (e.g., low education level 
of parents) contribute to the development of MD during youth. Due to the significance of 
traumatic experiences and psychosocial stressors, MD can be described as being stress-
related. Next to psychosocial adversity, genetic factors are also important influencing fac-
tors and interact with psychosocial stressors and traumatic experiences, heightening the 
risk of MD. For a better understanding of the factors contributing to MD, the present disser-
tation investigates the role of (a) psychosocial adversity differing in type and severity, (b) 
genetic factors, as well as (c) the interplay between these sources of risk, in the context of 
MD during youth. Publication I focuses on clinically depressed adolescents and typically 
developing peers. It addresses the interplay between qualitatively distinct psychosocial 
stressors and variation in FKBP5, a gene implicated in the physiological stress response. 
Results indicate interactions between genetic variation in FKBP5 (i.e., single nucleotide 
polymorphisms/SNPs, and the CATT haplotype consisting of minor alleles of several FKBP5 
SNPs) and different psychosocial stressors. In more detail, the probability for being diag-
nosed with MD increased depending on the number of moderate and sociodemographic 
stressors, as well as the total number of stressors experienced. This relationship was 
stronger in adolescents carrying at least one minor allele of different FKBP5 SNPS/at least 
one copy of the CATT haplotype.  
Publication II addresses the role of polygenic risk scores (PRS) for depression, as well as 
experiences of maltreatment. It could be shown that youths with heightened PRS and more 
incidences of maltreatment had a higher probability of being diagnosed with MD. Further-
more, higher PRS were associated with a younger age of onset and were also related to a 
higher level of depressive symptoms in conjunction with the experience of maltreatment in 
depressed patients. In an additional juvenile epidemiological sample, positive cross-
sectional and prospective longitudinal associations were found between PRS and maltreat-
ment, and heightened depressive symptoms.  
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Results from the two publications underline the importance of genetic factors and adverse 
psychosocial experiences, as well as their interplay, in the context of youth MD and depres-
sive symptoms. Following these results, important starting-points for efforts aiming at early 
identification, prevention, and treatment approaches can be deduced. In more detail, the 
publications clearly emphasize the relevance of different types and severities of psychoso-
cial adversity contributing to MD. This knowledge can play an important role in early identi-
fication and subsequent preventive efforts. Furthermore, in the long-run, PRS may have 
important implications for identifying youths at high risk of MD. Of note, knowledge on ge-
netic factors may ultimately guide treatment efforts; for instance, PRS may be included in 
diagnostics, treatment planning, as well as in the prevention of relapse and recurrence. Ad-
ditionally, FKBP5 might be an interesting target for the effects of antidepressant agents. 
Above all, implementing the combination of different sources of risk, i.e., genetic infor-
mation as well as psychosocial adversity, in identification, prevention, and treatment ap-
proaches in the context of MD during youth might be particularly fruitful. Next to focusing 
on risk factors for MD, expanding these analyses to protective factors might also offer im-
portant future insights with regard to clinical applications. 
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Deutsche Zusammenfassung 
 
Die Depression ist eine häufig vorkommende psychiatrische Erkrankung, die circa 7,5% 
der Jugendlichen betrifft. Die Erkrankung steht in Zusammenhang mit negativen Konse-
quenzen, wie Beeinträchtigungen in zwischenmenschlichen Beziehungen, Schwierigkeiten 
in der Schule sowie einem erhöhten Suizidrisiko. Die Faktoren, die einen Einfluss auf die 
komplexe Ätiologie der Depression haben, sind mannigfaltig. Vor allem traumatische Er-
lebnisse (z.B. Misshandlungserfahrungen) während besonders sensibler Entwicklungsperi-
oden, wie der Kindheit und Jugend, stellen wichtige Risikofaktoren dar und tragen zu einer 
Aufrechterhaltung der Depression bei. Darüber hinaus gelten alltägliche psychosoziale 
Stressoren, u.a. Probleme in der Schule oder im Familien- und Peerkontext als wichtige 
Faktoren in der Ätiologie der Depression im Kindes- und Jugendalter. Auch soziodemogra-
fische Stressoren (z.B. Bildungsgrad der Eltern) können eine wichtige Rolle in der Entste-
hung der Depression im Kindes- und Jugendalter einnehmen. Aufgrund der Relevanz trau-
matischer Erlebnisse sowie psychosozialer Stressoren gilt die Depression als stressbedingt. 
Neben psychosozialen Belastungsfaktoren spielen auch genetische Faktoren sowie das Zu-
sammenspiel dieser Faktoren eine bedeutende Rolle bei der Entstehung einer Depression 
und tragen zu einem erhöhten Depressionsrisiko bei. Um die Faktoren besser verstehen zu 
können, die einen Einfluss auf die Entwicklung einer Depression nehmen, wird in der vor-
liegenden Dissertation die Bedeutung (a) psychosozialer Belastungsfaktoren unterschiedli-
chen Typs und Schweregrads, (b) genetischer Faktoren sowie (c) des Zusammenspiels zwi-
schen diesen Faktoren im Kontext der Depression untersucht.  
Der Fokus von Publikation I liegt auf klinisch depressiven sowie gesunden Jugendlichen. 
Diese Publikation adressiert das Zusammenspiel zwischen qualitativ unterschiedlichen psy-
chosozialen Stressoren und Variation im FKBP5-Gen, das eine wichtige Rolle in der Regula-
tion der physiologischen Stressreaktivität spielt. Es zeigten sich Interaktionen zwischen 
Variation im FKBP5-Gen (Einzelnukleotidpolymorphismen/single nucleotide polymor-
phisms/SNPs sowie der CATT-Haplotyp bestehend als minoren Allelen unterschiedlicher 
FKBP5 SNPs) und unterschiedlichen psychosozialen Stressoren. Jugendliche, die eine er-
höhte Anzahl moderater und soziodemografischer Stressoren sowie eine erhöhte totale An-
zahl an Stressoren erlebt hatten, wiesen eine erhöhte Wahrscheinlichkeit auf, die Diagnose 
Depression erhalten zu haben. Diese Wahrscheinlichkeit war am höchsten bei denjenigen 
Jugendlichen, die mindestens ein minores Allel unterschiedlicher FKBP5 SNPs bzw. min-
destens eine Kopie des CATT-Haplotypen trugen.  
Publikation II adressiert die Bedeutung von polygenen Risikowerten für Depression (poly-
genic risk scores, PRS) sowie Misshandlungserfahrungen. Es konnte gezeigt werden, dass 
Kinder und Jugendliche mit der Diagnose einer Depression höhere PRS aufwiesen und häu-
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figer Misshandlungserfahrungen ausgesetzt waren als gesunde Altersgenossen. Zudem 
wurde ein Zusammenhang gefunden zwischen erhöhten PRS und einem jüngeren Erster-
krankungsalter. Es zeigte sich außerdem ein Zusammenhang zwischen PRS bzw. Misshand-
lungserfahrungen und einer schwereren depressiven Symptomatik bei depressiven Patien-
ten. In einer epidemiologischen Stichprobe bestehend aus Jugendlichen konnten sowohl 
querschnittliche als auch prospektive positive Zusammenhänge zwischen PRS, Misshand-
lungserfahrungen sowie erhöhten depressiven Symptomen gefunden werden.  
Die Ergebnisse der Publikationen unterstreichen die Bedeutung genetischer Faktoren und 
psychosozialer Belastungsfaktoren sowie ihres Zusammenspiels im Kontext der Depression 
im Kindes- und Jugendalter. Die Publikationen zeigen eine Reihe von Anknüpfungspunkten 
auf für frühe Maßnahmen zur Identifikation, Prävention sowie Behandlung der Depression 
im Kindes- und Jugendalter. So heben Publikation I und II deutlich die Relevanz psychoso-
zialer Stressoren unterschiedlichen Typs und Schweregrads hervor. Diese Erkenntnisse 
bieten wichtige Ansatzpunkte für die Identifikation von Kindern und Jugendlichen mit ei-
nem erhöhten Risiko für eine Depression und nachfolgenden präventiven Maßnahmen. PRS 
könnten längerfristig eine wesentliche Bedeutung einnehmen bei der Identifikation von 
Kindern und Jugendlichen, die ein erhöhtes Risiko für die Entwicklung einer Depression 
haben. Darüber hinaus könnte ein verbessertes Wissen bezüglich genetischer Risikofakto-
ren langfristig einen wichtigen Beitrag zur Therapie der Depression im Kindes- und Ju-
gendalter liefern; beispielsweise wäre es denkbar, PRS in Diagnostik, Planung von Behand-
lungen oder in die Prävention von Rückfällen und Rezidiven einzubeziehen. Das FKBP5-
Gen könnte zudem ein interessantes Ziel für antidepressive Medikation darstellen. Insbe-
sondere die gleichzeitige Einbeziehung unterschiedlicher Risiko- und Belastungsfaktoren, 
wie genetische Informationen und psychosoziale Stressoren, in Ansätzen zur Identifikation, 
Prävention und Behandlung der Depression im Kindes- und Jugendalter erscheint vielver-
sprechend. In Hinblick auf klinische Anwendungsbereiche wäre es bedeutsam, in zukünfti-
gen Studien neben Risikofaktoren für die Depression auch protektive Faktoren zu betrach-
ten.  
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Introduction to the cumulative dissertation  
 
The burden of major depression in youth 
 
Major Depression (MD) is a prevalent psychiatric disorder with more than 300 million indi-
viduals being affected worldwide.1 While MD can occur at any time during the life span, 
prevalence rates are relatively low during childhood, but markedly rise thereafter, with at 
least 7.5% of adolescents suffering from the disorder.2,3 Youth MD is associated with a re-
duced functioning in school, peer and family contexts and a heightened risk of suicide.2-5 
Moreover, MD during youth is characterized by a heightened rate of recurrence and an in-
creased risk of chronification, as well as difficulties related to work, social and academic 
contexts that can persist into adulthood.4 Relatedly, subsyndromal depressive symptoms, 
which represent a major risk factor of developing MD, are a prevalent phenomenon with 
8.2% of youths reporting elevated depressive symptoms.6,7 It is notable that suffering from 
heightened depressive symptoms during youth is associated with, e.g., impairment affect-
ing the individual’s school career and negative effects in adulthood, including difficulties in 
interpersonal relationships and lower levels of education and income.7-9 For these reasons, 
MD during youth represents a significant challenge for the society and healthcare system, 
as well as for science.  
 
Although effective approaches for preventing and treating MD do exist, their effects are 
usually small or not more than moderate.10-13 This can in part be attributed to the etiological 
complexity of MD, as well as to the fact that contributing factors are still not sufficiently 
understood. These factors include the biological underpinnings of the disorder, e.g., genet-
ic factors, as well as their interplay with psychosocial factors. Notwithstanding, progress 
has been made in advancing knowledge of biological aspects contributing to the develop-
ment and maintenance of MD, e.g., by identifying genetic and epigenetic factors.14,15 In the 
same vein, the importance of psychosocial adversity in the context of MD seems indisputa-
ble.16 It is therefore crucial to come to a better understanding of the biological and psycho-
social factors contributing to MD in youth and of their interplay, in order to increase efforts 
aiming at (a) the identification of youths with high risk, and (b) related preventive efforts, as 
well as (c) the further development of treatment options.14  
 
Developmental processes during youth 
 
The developmental period of youth is characterized by normative changes in biological sys-
tems, such as the maturation of the hypothalamic-pituitary-adrenal (HPA)-axis, which rep-
resents a major stress system.17,18 During puberty individuals experience a rise in the 
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amount of stress, especially occurring in the psychosocial environment. In addition, youths 
tend to show a heightened emotional responsivity towards these stressors and do not own 
fully elaborated strategies to avoid or counteract stress.18-20  These factors render youths 
vulnerable to developing MD and contribute to the increase in prevalence rates.18-20 Of 
note, youth can be regarded as a particular sensitive and plastic developmental period.21,22 
That is, youths are especially receptive to experiences, so that adversity during this time 
can have profound and long-lasting effects on developing stress systems, such as the HPA-
axis.17,21 The repeated experience of stress over a prolonged period of time can have a wide 
range of adverse effects on health, including an increased risk of psychiatric disorder like 
MD.17 MD during youth is associated with intensive personal suffering and can have detri-
mental effects on the current and future development. Therefore, it seems especially rele-
vant and promising with regard to identification, prevention and treatment efforts to identi-
fy factors contributing to MD during this developmental period.2-5  
 
Psychosocial and genetic factors contributing to major depression 
 
MD is a complex psychiatric disorder with many interrelated biological, psychosocial and 
cognitive factors being implicated.3 As adversity in the (psychosocial) environment often 
precipitates MD, it can be conceptualized as being stress-related.23-25 Previous research has 
shown that early traumatic experiences, such as physical maltreatment or sexual abuse, 
have a strong effect on the development of MD.26 Additionally, also relatively common and 
less severe psychosocial stressors, which are part of everyday life, including conflict with 
parents and peers or problems at school, represent important factors contributing to the 
disorder.3,27,28 In addition, it has been demonstrated that sociodemographic characteristics 
of the family, such as a low academic qualification of the parents, are linked to MD via its 
associations with heightened levels of other (psychosocial) stressors.29 The frequent and 
intense experience of stress can lead to a dysregulation of the HPA-axis, which may predis-
pose youths towards developing MD.17 Consequently, a large number of juvenile patients 
suffering from MD show elevated levels of cortisol, reflecting functional alterations of the 
HPA-axis.30  
 
Next to psychosocial adversity, it is known that MD has a genetic component.3 These genet-
ic factors explain about 40% of the variation in MD during adolescence.31 In addition to 
family/twin studies aiming at estimating the genetic and environmental proportions con-
tributing to MD, different approaches exist, which address molecular genetic factors. The 
candidate-gene approach, for instance, focuses on the identification of variation in specific 
genes likely implicated in MD.32 This approach is guided by existing theories on the biolog-
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ical bases of MD. It often focuses on investigating single nucleotide polymorphisms (SNPs), 
which are common changes in single bases of the DNA.32,33 For instance, knowledge of the 
depletion of monoaminergic neurotransmitters, such as serotonin, in depressed patients 
has inspired researchers to investigate genetic variation underlying putative mechanisms, 
e.g. by examining genetic variants in the gene coding for the serotonin transporter 
(SLC6A4).34,35 Further well-studied candidate genes are those coding for other proteins 
related to monoaminergic neurotransmission, such as dopamine receptors or the dopamine 
transporter (e.g., DRD2, SLC6A3).36,37 Other frequently studied candidate-genes are those 
coding for proteins being involved in the regulation of the HPA-axis, including FKBP51 (i.e., 
the FKBP5-gene).38,39 
 
FKBP5 is a well-studied gene and is implicated in the physiological stress response.40 Fol-
lowing an acute stressor, the HPA-axis is being activated and releases, amongst other pep-
tides, glucocorticoids, including cortisol. Cortisol, in turn, binds to the glucocorticoid recep-
tor (GR), which initiates a negative feedback loop with the goal of terminating the physio-
logical stress response.41 The activation of the GR is related to an increased transcription of 
FKBP5 with associated heightened FKBP51 levels.42,43 FKBP51, in turn, binds to the GR, 
inhibiting the suppression of the HPA-axis. This results in a subsequent prolonged physio-
logical stress response, as reflected by, e.g., heightened levels of cortisol.44,45 Genetic varia-
tion in FKBP5 has been extensively studied in the realm of HPA-axis (dys-)regulation, the 
(psychosocial) reactivity towards stress, antidepressant treatment response, emotion regu-
lation, and interactions with traumatic and stressful life events in the context of stress-
related disorders, including MD.46-51 
 
While the candidate-gene approach is strictly theory-driven, investigating variation in a sin-
gle gene cannot accommodate the conceptualization of MD as a polygenic disorder arising 
from variation in many genes.32,52 In line, recent investigations of the genetic bases of MD 
have focused on conducting genome-wide association studies (GWAS).53-55 GWASs focus on 
SNPs and follow a theory-free, data-driven approach in which frequencies of alleles across 
the genome are compared between affected (e.g., those with depression) and healthy indi-
viduals.54 Resulting identified alleles can then be used to calculate polygenic risk scores 
(PRS). PRS are thought to capture genetic variance in many genes with small effect sizes 
each and higher PRS reflect an increased genetic liability to the phenotype studied in the 
GWAS, e.g., depression.54 
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Gene-environment interactions in major depression 
 
While MD has a genetic basis, genetic contributions to MD are small to moderate and other 
factors, such as psychosocial adversity considerably contribute to the disorder.56,57 It needs 
to be noted, however, that not all individuals experiencing psychosocial stressors or even 
traumatic experiences develop MD. Likewise, a genetic vulnerability to MD, e.g., reflected 
in heightened PRS, does not necessarily lead to the disorder. These findings point to the 
notion that genetic factors and environmental stressors may interplay, a concept known as 
gene-environment interactions (G×E) as derived from the diathesis-stress model.58-60 In par-
ticular, psychosocial adversity can modulate the relationship between genetic risk and MD, 
and vice versa.22,59 Following the diathesis-stress model, genetic risk and adverse psycho-
social experiences need to come together in order to contribute to an increase of the likeli-
hood of developing MD.58,60 In more detail, genetic factors can provide the diathesis to 
which different forms and intensities of adverse experiences can add up. When stressors of 
a certain intensity add to the diathesis, they will likely cross a critical point in the model, 
which facilitates the development of MD.58,60 
 
Investigating different types and grades of severity of psychosocial adversity and genetic 
factors implicated in MD, as well as their interplay, cannot only contribute to a better un-
derstanding of possible mechanisms, which convey heightened risk of the disorder. This 
approach also offers the possibility for informing efforts for the identification, prevention 
and treatment of MD. First, knowledge about psychosocial adversity can help identifying 
youths at risk of developing MD. Second, many adverse psychosocial experiences can be 
prevented and the (emotional) reactions to them are often amenable to change. This offers 
starting-points for early preventive efforts and provides possible targets for treatment, e.g., 
cognitive-behavioral interventions. Third, with increasing insights on genetic factors con-
tributing to MD, it is conceivable that this knowledge might help to identify youths with a 
heightened genetic risk for MD in the long-run. This, in turn, might be beneficial for early 
preventive and diagnostic efforts. Fourth, knowledge on genetic risk factors for MD may 
also have implications for treatment, e.g., by identifying youths at high risk of non-response 
or relapse following (pharmacological) treatment or by aiding in psychopharmacological 
treatment selection.61 Fifth, the joint analysis of psychosocial adversity and genetic factors 
may be especially worthwhile since MD results from a complex interplay of different genet-
ic, as well as other (e.g., psychosocial) factors. Combining information from several poten-
tial sources contributing to MD will likely be more beneficial than relying on one field of 
risk alone, especially with regard to early identification and prevention, as well as treatment 
efforts.62  
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Aim and results of the two studies 
 
The objective of the two studies was to examine genetic factors and psychosocial adversity, 
as well as their interplay, in youth MD.57,63 The two investigations follow different ap-
proaches regarding the conceptualization of (a) the genetic diathesis and (b) psychosocial 
adversity. Importantly, they include children and adolescents and thereby cover especially 
sensitive developmental periods.21,22 In addition to the focus on MD, one of the studies ad-
ditionally addresses (subsyndromal) depressive symptoms, thereby including two important 
aspects of the broader spectrum of depression. Together, the two studies complement each 
other by targeting different facets of the research question of how genetic factors, psycho-
social adversity and their interplay contribute to MD in youth.  
 
Publication I63 focuses on variation in the FKBP5-gene and different types and severities of 
psychosocial stressors in adolescents diagnosed with a current episode of MD, as well as 
healthy peers. Five FKBP5 SNPs, as well as the CATT haplotype (consisting of the minor 
alleles of four of these SNPs), were selected to investigate the genetic diathesis. To examine 
psychosocial adversity, a broad range of qualitatively distinct psychosocial stressors, which 
are particularly relevant during adolescence, were assessed (e.g., difficulties at school or in 
the peer context). These individual stressors were judged by the adolescents with respect to 
their perceived stressfulness. This approach allowed a classification of the individual 
stressors as mild, moderate or severe. Moreover, sociodemographic stressors were as-
sessed on the basis of parental-report and are thought to reflect a more stable background 
condition of psychosocial adversity. Additionally, in order to depict a total measure of 
stressors experienced, a sum score was created by adding all individual mild, moderate, 
severe, and sociodemographic stressors. The main analyses of the study focused on interac-
tions between FKBP5 SNPs/the CATT haplotype and the different psychosocial stressors. 
Interactions were found between different SNPs/the CATT haplotype and moderate and 
sociodemographic stressors, as well as the total number of stressors experienced. The 
probability for being diagnosed with MD rose depending on an increasing number of mod-
erate and sociodemographic stressors, as well as a growing number of total stressors expe-
rienced, respectively. This relationship was stronger in adolescents who carried at least one 
minor allele/one copy of the CATT haplotype, as compared with adolescents who were ho-
mozygous for the major allele/did not carry a copy of the CATT haplotype.  
 
In Publication II57 PRS, experiences of maltreatment, as well as their interactions were 
tested in a clinical sample of youths with a diagnosis of MD, and in a control group consist-
ing of youths who were free of current and past psychiatric disorders. Results showed a 
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relationship between PRS and case-control status, i.e., youths with a higher PRS had a 
higher probability of being diagnosed with MD. Furthermore, in youths with MD, there was 
an association between PRS and age of onset, and severity of the depressive symptomatol-
ogy, respectively. In more detail, a higher PRS was linked to a younger age of onset and a 
heightened level of depressive symptoms. In addition, additive effects of PRS and experi-
ences of maltreatment were found. That is, heightened PRS and a higher incidence of mal-
treatment were both related to a heightened probability of being diagnosed with MD and a 
more severe depressive symptomatology. Furthermore, in this study, a juvenile epidemio-
logical cohort was investigated. In this sample, a positive cross-sectional relationship was 
found between PRS and depressive symptoms. This association could be replicated in a 
community sample consisting of children, which was also investigated in this study. Inter-
estingly, in the epidemiological sample, youths who did not show evidence of heightened 
depressive symptoms at the first point of measurement, but had moderate to severe depres-
sive symptoms two years later, had higher PRS than individuals with no or mild symptoms. 
Additive effects of the PRS and experiences of maltreatment were found cross-sectionally, 
as well as in the prospective longitudinal analyses. 
 
Discussion of the two publications and future prospects 
 
By addressing different genetic factors and psychosocial adversities contributing to MD 
during youth, the two publications add to and advance knowledge of the complex etiology 
of MD during this sensitive developmental period. Therefore, important starting-points for 
(a) an early identification of individuals with a heightened risk of MD with subsequent pre-
ventive efforts, and (b) treatment can be deduced from the present findings. 
 
First, results from both studies shed light on the relevance of different types and grades of 
severity of psychosocial adversity in the context of youth MD. It could be shown that trau-
matic experiences, such as maltreatment as well as more common and less severe psycho-
social stressors (e.g., arguments with parents), substantially influence the development of 
MD and represent potent sources of risk. Moreover, as shown previously, these factors sub-
stantially contribute to the development of MD.31,56 Hence, identifying youths who experi-
ence a great amount of different psychosocial stressors and those who even experience(d) 
traumatic life events would be an important first step towards identification and early pre-
vention efforts. Importantly, Publication I addresses sociodemographic stressors. These 
factors are an important source of risk as they are assumed to not only reflect a considera-
ble burden on their own. In line, it is known that they also convey a heightened risk of MD 
through their association with other stressors.29 Sociodemographic stressors, such as the 
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academic qualification of the parents, cannot easily be addressed based on early interven-
tions. Therefore, it is important to especially target youths who experience an elevated 
number of sociodemographic stressors when trying to prevent MD. This could be achieved, 
e.g., by approaching youths from lower sociodemographic backgrounds via schools. An 
additional benefit may be reached by identifying highly stressed youths who have parents 
who suffer from MD, as this is a highly potent (environmentally and genetically mediated) 
risk factor of MD.64 
 
Second, while genotypic vulnerability is fixed, potential adverse effects of psychosocial ad-
versity can be buffered in order to prevent the development of MD. As adversity during 
youth can have unfavorable consequences for well-being and mental health, it is important 
to consider that youth is also a sensitive period in which effective interventions can have 
especially favorable effects on future development.21,65 For instance, emotional reactions to 
mild to moderate daily stressors (e.g., quarreling with parents) are not static, but can be 
modified. Therefore, for instance, youths could first be identified, who experience a height-
ened level of controllable daily stressors. Teaching them how to cope with these stressors 
through emotion regulation might be a worthwhile endeavor to avoid or reduce the nega-
tive emotional consequences of stress and to contribute to an increase in well-being and 
mental health.66 In this vein, one possibility would be to teach youths to cope by means of 
cognitive reappraisal, i.e. they can be trained in generating more positive interpretations of 
negative experiences with the aim of ameliorating negative affect.67 Moreover, severe ad-
verse psychosocial experiences, such as maltreatment, especially when occurring very early 
during development, represent potent risk factors for MD and their negative (physiological) 
effects are usually long-lasting.26 Since effective strategies for preventing childhood mal-
treatment are available, those efforts should be promoted in order to contribute to the pre-
vention of MD. These approaches often consist of parental education with the aim of en-
hancing positive parenting behavior and providing information about child 
development.68,69 Intense home visitations as early as during the prenatal period until in-
fancy seem especially promising for the reduction of child maltreatment, particularly when 
high-risk populations are targeted (e.g., very young parents, single mothers or families with 
a low socio-economic background).70  
 
Third, PRS might offer the chance for the identification of youth at high risk of MD. Publica-
tion II has shown that PRS for depression differ between youths with MD and their typically 
developing peers and can predict subsyndromal depressive symptoms over time. It also 
became evident, however, that PRS of depressed and healthy youths overlap substantially. 
Likewise, mean group values of PRS between youths with MD and their healthy counter-
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parts, as well as between youths from the community with low vs. high depressive symp-
toms differ only slightly from each other.71 Therefore, while PRS reflect genetic liability 
towards MD and subsyndromal depressive symptoms, they can currently not be used for 
predicting individual risk.62,71 Notably, the PRS used in Publication II were derived from a 
large GWAS including adults.55 Publication II could demonstrate that these PRS are also 
associated with clinical characteristics of MD in a sample of youths. In spite of that, it needs 
to be emphasized that the original GWAS, on which the PRS were based, focused on a 
broader spectrum of depression and did not exclusively rely on case-control samples con-
sisting of clinically ascertained MD cases. Additionally, prospective predictions of the PRS 
in Publication II were restricted to the epidemiological sample and it was not explicitly 
studied whether heightened PRS might also predict future incidences of MD. Consequently, 
these issues could be important starting-points for future investigations examining the pre-
diction of a full-blown episode via PRS in a sample of youths. Furthermore, there are indica-
tions showing that PRS do not seem to be specific for the disorder studied in the respective 
GWAS.72 Thus, it would be important to investigate in future studies in what way specific 
PRS relate to distinct psychiatric disorders or to establish associations between PRS and 
distinct constellations of symptoms or intermediate phenotypes.73 Despite these limitations, 
PRS for depression is a highly promising target with regard to clinical applications. It is 
conceivable that they can contribute to an improved identification of individuals with a high 
genetic risk of MD that may add to clinical information, such as a family history of MD in 
the future.62,71,73  
 
Fourth, advanced knowledge on genetic factors contributing to MD might play an important 
role for the treatment of the disorder. As shown in Publication II, the genetic contribution to 
MD seems to be higher in more severely affected youths, as reflected in a positive relation-
ship between PRS and heightened depressive symptoms. There are indications showing 
that an earlier age of onset represents a more severe form of MD.4 Offspring from parents 
with an affective disorder tend to have a younger age of onset than those without affected 
parents.74,75 This likely reflects heightened genetic risk of the disorder, which is in line with 
the finding in Publication II demonstrating a relationship between PRS and a younger age 
of onset. These insights concerning the contribution of molecular genetic factors to the se-
verity of MD might play an important role in the planning of treatment, as well as relapse 
and recurrence prevention after treatment has ended. It is known that a more serious 
course of MD is associated with less favorable outcomes.4 In line, knowledge about height-
ened genetic liability towards MD, which apparently reflects more severe forms of the dis-
order, can sensitize clinical practitioners, as well as depressed patients and their families to 
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take action for relapse and recurrence prevention and early treatment when depressive 
symptoms recur.  
Moreover, since the candidate gene approach derives its target genes from theoretical 
models of the underlying biological mechanisms supposed to govern MD, these studies 
offer an important starting-point for a better understanding of the mechanisms of antide-
pressant agents.76 For instance, it could be shown that antidepressant medications influ-
ence FKBP5 expression and that this association is especially strong in minor allele carri-
ers.77 Furthermore, adult FKBP5 minor allele carriers show a faster response to antidepres-
sant medication.46 It is conceivable that molecular genetic information in concert with other 
information, such as clinical characteristics, might aid guiding pharmacological treatment 
selection for individual patients in the long run.78 
 
Fifth, as has been shown by Publication II, combining PRS and psychosocial adversity could 
increase the variance explained in clinical characteristics of MD and subsyndromal depres-
sive symptoms. Therefore, it would be especially promising to make use of more than one 
risk source for ameliorating early identification, prevention, and treatment efforts.62,71 Until 
now, genetic risk of MD is commonly inferred from a positive family history of an affective 
disorder. It needs to be proven if PRS in combination with information on familial history, 
as well as psychosocial adversity might improve predictive accuracy with regard to the de-
velopment of MD.73 This knowledge could then be used to enhance early identification, pre-
vention, diagnostic and treatment approaches. It is important to consider that the genetic 
basis of MD is complex. Next to SNPs, also less common genetic variation, such as copy 
number variants (CNVs) might contribute to MD risk.14 In addition, epigenetic changes, 
such as differing methylation levels, are likewise not captured by PRS, but also convey 
heightened vulnerability for the disorder.15 
 
It would therefore be worthwhile in future studies to examine the role of epigenetic chang-
es in the context of juvenile MD. Since these changes are not fixed, but highly sensitive to 
the environment, e.g., to psychosocial adversity, these factors also offer an important win-
dow for preventive and treatment options.79 Likewise, by investigating the relationship be-
tween MD and stress more closely, it would be fruitful to focus on the association between 
genetic factors, psychosocial adversity, as well as potential intermediate phenotypes of MD, 
such as structural and functional brain changes and endocrine markers of stress, such as 
cortisol levels.40,80,81 In the light of efforts aiming at identifying, preventing, and treating 
MD, it would also be highly important to gain more insight into the complex interplay be-
tween potential risk and protective factors. In contrast to the diathesis-stress model, the 
differential susceptibility model points out that carrying a certain diathesis (e.g., minor 
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FKBP5 SNPs or heightened PRS) might lead to a negative outcome when adversity is high. 
Likewise, when confronted with a positive, nurturing and supportive environment, individu-
als who have a heightened diathesis for MD might fare better than individuals without such 
a diathesis who experience a comparable positive environment.82 This is also in agreement 
with the conceptualization of youth as a particular plastic and sensitive developmental peri-
od, with environmental experiences having the potential to lead to negative and positive 
outcomes, respectively.21,22 
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